Expression and characterization of recombinant bovine lactoferrin in E. coli

BioMetals

Volumn 26, Issue 1, 2013, Pages 113-122

  García Montoya, Isui ^a   Salazar Martínez, Jose ^b   Arévalo Gallegos, Sigifredo ^a   Sinagawa García, Sugey ^c   Rascón Cruz, Quintin ^a  

^a UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

^b Proteo/Muu Technologies de Mexico   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Affinity chromatography; Antibacterial activity; Bovine lactoferrin; Fusion expression; Thrombin

Indexed keywords

ANTIINFECTIVE AGENT; LACTOFERRICIN; RECOMBINANT BOVINE LACTOFERRIN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BETA SHEET; CONTROLLED STUDY; DRUG IDENTIFICATION; ESCHERICHIA COLI; GROWTH INHIBITION; IMMUNOMODULATION; IRON BINDING CAPACITY; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

BOVINAE; NEGIBACTERIA; POSIBACTERIA;

EID: 84873405565     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-012-9598-7     Document Type: Article

References (39)

1. Adlerova L, Bartoskova A, Faldyna M (2008) Lactoferrin: A review. Vet Med 53:457-468
2. Anderson BF, Baker HM, Dodson EJ, Norris GE, Rumball SV, Waters JM, Baker EN (1987) Structure of human lactoferrin at 3.2-A resolution. Proc Natl Acad Sci USA 84: 1769-1773
3. Arnold K, Kiefer F, Kopp J, Battey JND, Podvinec M, Westbrook JD, Berman HM, Bordoli L, Schwede T (2009) The protein model portal. J Struct Funct Genomics 10:1-8
4. Baker EN, Baker HM (2005) Molecular structure, binding and dynamics of lactoferrin. Cell Mol Life Sci 62:2531-2539
5. Baker EN, Baker HM (2009) A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 91:3-10
6. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita (1992) Anti-bacterial spectrum of lactoferrin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J App Bateriol 73:472-479
7. Box GEP, Behnken DW (1960) Some new three level designs for the study of quantitative variables. Technometrics 2: 455-475
8. Brock J (2002) The physiology of lactoferrin. Biochem Cell Biol 80:1-6
9. Carpenter MA, Broad TE (1993) The cDNA sequence of horse transferrin. Biochim Biophys Acta 1173:230-232
10. Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW (1998) Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface reginon human lactoferrin against Escherichia coli serotype O111. Infection Immun 66:2434-2440
11. Choi BK, Actor JK, Rios S, d'anjou M, Stadheim TA, Warburton S, Giaccone E, Cukan M, Li H, Kull A, Sharkey N, Gollnick P, Kocieba M, Artym J, Zimecki M, Kruzel ML, Wildt S (2008) Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: Effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj J 25:581-593
12. Cura V, Gangloff M, Elier S, Moras M, Ruff M (2007) Cleaved thioredoxin fusion protein enables the crystallization of poorly soluble ER in complex with synthetic ligands. Acta Crystallogr F 64:54-57
13. Elbarbary HA, Abdou AM, Young-Park Y, Nakamura Y, Mohamed HA, Sato K (2010) Novel antibacterial lactoferrin peptides generated by rennet digestion and autofocusing technique. Int Dairy Sci 20:646-651
14. Feng XJ, Wang JH, Shan AS, Teng D, Yang YL, Yao Y, Yang GP, Shao YC, Liu S, Zhang F (2006) Fusion expression of bovine lactoferricin in Eschericha coli. Protein Express Purif 47:110-117
15. Flores-Villasenor H, Canizalez-Román A, Reyes-Lopez M, Mazmi K, de la Garza M, Zazueta-Beltrán J, León-Sicairos N, Bolscher JGM (2010) Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibioticresistant Staphylococcus aureus and Escherichia coli. Biometals 23:569-578
16. García-Montoya IA, Siqueiros-Cendon T, Arévalo-Gallegos S, Rascón-Cruz Q (2012) Lactoferrin a multiple bioactive protein: An overview. BBA-Gen Subjects 1820:226-236
17. Gonzalez-Chavez SA, Are'valo-Gallegos S, Rasco'n-Cruz Q (2009) Lactoferrin: Structure, function and applications. Int J Antimicrob Agents 33:301
18. Jameson GB, Anderson BF, Norris GE, Thomas DH, Baker EN (1998) Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change. Acta Crystallogr D54:1319-1335
19. Kim HK, Chun DS, Kim JS, Yun CH, Lee JH, Hong SK, Kang DK (2006) Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Appl Microbiol Biotechnol 72:330-338
20. Lee JH,KimJH,HwangSW, LeeWJ,YoonHK,LeeHS,HongSS (2000) High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem Biophys Res Commun 277:575-580
21. Lonnerdal B (2010) Bioactive proteins in human milk: Mechanisms of action. J Pediatrics 156:S26-S30
22. Masson PL, Heremans FJ, Dive CH (1966) An iron-binding protein common to many external secretions. Clin Chim Acta 14:735-739
23. Montgomery DC (1997) Design and analysis of experiments. Response surface methods and other approaches to process optimization. Wiley, New York, pp 372-422
24. Moore SA, Anderson BF, Groom CR, Haridas M, Baker EN (1997) Three-dimensional structure of diferric bovine lactoferrin at 2.8 angstrom resolution. J Mol Biol 274: 222-236
25. Orsi N (2004) The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals 17:189-196
26. Park JH, Park GT, Cho IH, Sim SM, Yang JM, Lee DY (2011) An antimicrobial protein, lactoferrin exists in the sweat: Proteomic analysis of sweat. Exp Dermatol 20:369-371
27. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25:1605-1612
28. Stark M, Liu L, Deber (2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother 46:3585-3590
29. Tian ZG, Teng D, Yang YL, Luo J, Feng XJ, Fan Y, Zhang F, Wang JH (2007) Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4, 10 in Escherichia coli. Appl Mircobiol Biotechnol 75:117-124
30. Tomita M, Bellamy W, Takase M, Yamauchi H, Kawase K (1991) Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 74:4137-4142
31. Tomita M, Wakabayashi H, Yamauchi Teraguchi S, Hayasawa H (2002) Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem Cell Biol 80:109-112
32. van der Kraan MI, Groenink J, Nazmi K, Veerman EC, Bolscher JG, Nieuw Amerongen AV (2004) Lactoferrin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25:177-183
33. Vogel HJ, Schibli DJ, Jing W, Lohmeier-Vogel EM, Epand RF, EpandRM(2002) Towards a structure-function analysis of bovine lactoferricin and related tryptophan-and argininecontaining peptides. Biochem Cell Biol 80:49-63
34. Wally J, Buchanan SK (2007) A structural comparison of human serum transferrin and human lactoferrin. Biometals 20: 249-262
35. Wang J, Tian Z, Teng D, Yang Y, Hu J, Wang J (2001) Cloning, expression and characterization of kunming lactoferrin and its N-Lobe. Biometals 23:523-530
36. Wright O, Yoshimi T, Tunnacliffe A (2012) Recombinant production of cathelicidin-derived antimicrobial peptides in Escherichia coli using an inducible autocleaving enzyme tag. New Biotechnol 29:352-358
37. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI (2007) Human polymorphonuclear leukocytes inhibits Aspergillus fumigatus conidial growth by lactoferrinmediated iron depletion. J Immunol 178:6367-6373
38. Zhang H, Yoshida S, Aizawa T, Murakami R, Suzuki M, Koganezawa N, Matsuura A, Miyazawa M, Kawano K, Nitta K, Kato Y (2000) In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum. Antimicrob Agents Chemother 44:2701-2705
39. Zorko M, Jerala R (2010) Production of recombinant antimicrobial peptides in bacteria. Methods Mol Biol 618:61-76